Two studies, led by Kathy Niakan at Cambridge University and Dieter Egli at Columbia University, have reignited the debate on embryo gene editing. Using base editing, researchers are investigating how genetic material can be modified to prevent children from developing certain diseases, though the practice is not yet a medical reality.
Clinical Essentials of Embryo Modification
- Base Editing: A technique developed in 2016 to alter genetic material with greater precision than earlier methods.
- The Mosaicism Hurdle: A phenomenon that happens when base-editor molecules fail to find and modify certain cells. This could potentially cause the development of certain diseases.
- Regulatory Status: No country allows the modification of cells that can be passed on to offspring.
Advancing Precision in Genomic Alteration
The research published this summer represents a shift from conventional gene-editing tools. Researchers working with Kathy Niakan at Cambridge University employed base editing to focus on NANOG, a specific gene identified as vital for the development of embryos into future bodies. Niakan suggests that base editing is a major improvement over standard CRISPR-Cas9, noting that it brings a much smaller possibility of creating accidental chromosomal damage.
In the United States, the team at Columbia University under the direction of Dieter Egli used these methods on a trio of genes: one associated with cardiovascular disease and high cholesterol, and two others associated with the creation of haemoglobin. The researchers stated their goal is to discover methods for avoiding developmental and genetic defects throughout IVF, with the aim of developing fertility care that is more affordable, safer, and more effective.
Addressing the Mosaicism and Ethical Barriers
Despite the technical progress, the scientific community remains cautious. Robin Lovell-Badge, principal group leader and head of the laboratory of stem cell biology and developmental genetics at the Francis Crick Institute in London, noted that while the methods look much safer, there is still work to do. Because the editing levels of mosaicism are low, but not zero, he noted there is going to have to be more work done there.
The ethical discourse centers on the tension between therapy versus enhancement. Pascal Borry, professor of bioethics at the University of Leuven, in Belgium, emphasizes that society must define where the line is between therapeutic and improvement. There is also the question of necessity; many genetic conditions can be managed through pre-implantation genetic testing, which takes place during in vitro fertilisation treatment to detect any abnormalities in the embryos.
| Technique | Primary Mechanism | Safety Advantage |
|---|---|---|
| CRISPR-Cas9 | Conventional | Higher risk of unintended chromosome errors |
| Base Editing | Base editing | Far lower risk of unintended chromosome errors |
Contraindications & When to Consult a Doctor
Embryo gene editing is not yet a medical reality. Individuals seeking to avoid the transmission of hereditary genetic disorders should consult with a professional. These professionals utilize methods such as pre-implantation genetic testing to detect any abnormalities in the embryos during the IVF process.
Regulatory and Future Trajectories
The debate surrounding these studies highlights the tension between innovation and caution. While some researchers, like Robin Lovell-Badge, argue that it is unethical to allow people to have children that have a genetic disorder if you can avoid it, he also argues that countries should regulate the practice; however, they should not adopt a restrictive ban. As the research continues, the focus will remain on refining the precision of base editors.
